MedTrace Logo

DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY

NCT06425497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-05-29

No results posted yet for this study

Summary

To investigate the variations of Donor Specific Antibodies in kidney transplant patients based on the type of immunosuppressive therapy adopted and immunosuppressive blood levels.

Conditions

  • Kidney Transplant; Complications
  • Immunosuppression

Interventions

OTHER

The dosage of dnDSA

Flow cytometric analysis using FlowPRA Screening Test and/or Luminex Single Antigen Beads class I and II- IgG (cut- positivity off = MFI\> 1000)

Sponsors & Collaborators

  • University of Rome Tor Vergata

    lead OTHER

Principal Investigators

  • Roberta Angelico, MD · Università degli studi di Roma Tor Vergata

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2023-07-31
Completion
2024-05-06

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06425497 on ClinicalTrials.gov